tegafur has been researched along with Margins of Excision in 2 studies
Margins of Excision: The edges of tissue removed in a surgery for assessment of the effectiveness of a surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. When the margin is negative or not involved by tumor (e.g., CANCER) it suggests all of the tumor has been removed by the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It was unclear whether the transhiatal approach and D2 total gastrectomy after neoadjuvant chemotherapy (NAC) for adenocarcinoma of the esophago-gastric (AEG) junction are as feasible and safe as D2 gastrectomy following NAC." | 2.82 | Feasibility and Safety of Transhiatal Approach and D2 Total Gastrectomy after Neoadjuvant Chemotherapy for Adenocarcinoma of the Esophago-Gastric Junction: A Subset Analysis of the COMPASS Trial. ( Aoyama, T; Cho, H; Hayashi, T; Ito, Y; Miyashita, Y; Nishikawa, K; Sakamoto, J; Tanabe, K; Tsuburaya, A; Yoshikawa, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okano, K | 1 |
| Suto, H | 1 |
| Oshima, M | 1 |
| Maeda, E | 1 |
| Yamamoto, N | 1 |
| Kakinoki, K | 1 |
| Kamada, H | 1 |
| Masaki, T | 1 |
| Takahashi, S | 1 |
| Shibata, T | 1 |
| Suzuki, Y | 1 |
| Yoshikawa, T | 1 |
| Aoyama, T | 1 |
| Tanabe, K | 1 |
| Nishikawa, K | 1 |
| Ito, Y | 1 |
| Hayashi, T | 1 |
| Cho, H | 1 |
| Miyashita, Y | 1 |
| Tsuburaya, A | 1 |
| Sakamoto, J | 1 |
2 trials available for tegafur and Margins of Excision
| Article | Year |
|---|---|
A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Chemo | 2017 |
Feasibility and Safety of Transhiatal Approach and D2 Total Gastrectomy after Neoadjuvant Chemotherapy for Adenocarcinoma of the Esophago-Gastric Junction: A Subset Analysis of the COMPASS Trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2016 |